You have 9 free searches left this month | for more free features.

Subcutaneous dose

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers Trial in Tempe, Lincoln (Nemolizumab)

Completed
  • Healthy Volunteers
  • Tempe, Arizona
  • +1 more
Dec 13, 2022

Heathy Participants Trial (AZD7053, Placebo)

Not yet recruiting
  • Heathy Participants
  • (no location specified)
Oct 19, 2023

IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • (no location specified)
Oct 27, 2023

Healthy Trial in Shanghai (Recifercept)

Not yet recruiting
  • Healthy
  • Shanghai, Shanghai, China
  • +1 more
Jan 4, 2023

Hepatic Impairment, Healthy Volunteers Trial in München, Gdansk, Bratislava (NNC0194-0499)

Not yet recruiting
  • Hepatic Impairment
  • Healthy Volunteers
  • München, Germany
  • +2 more
Jun 27, 2023

Healthy Participants Trial in Sumida-ku (AZD2693, Placebo)

Active, not recruiting
  • Healthy Participants
  • Sumida-ku, Japan
    Research Site
Jan 18, 2023

Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))

Not yet recruiting
  • Healthy Men
  • BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
  • Hefei, Anhui, China
    The Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023

Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • STSA-1301 subcutaneous injection
  • Placebo
  • Beijing, Chaoyang District, China
    Beijing Ditan Hospital,Capital Medical University
Nov 28, 2023

End of Dose Phenomena in Subcutaneous Natalizumab Treated

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Jan 18, 2023

Healthy Volunteers Trial in Hialeah (Amlitelimab DP1, Amlitelimab DP2)

Active, not recruiting
  • Healthy Volunteers
  • Amlitelimab DP1
  • Amlitelimab DP2
  • Hialeah, Florida
    Clinical Pharmacology of Miami-Site Number: 8400001
Mar 29, 2023

Inflammatory Bowel Disease Trial in Beijing (450mg, 150mg, Placebo)

Completed
  • Inflammatory Bowel Disease
  • Beijing, Beijing, China
    Peking University Third Hospital
Jul 7, 2022

Antineutrophil Cytoplasmic Antibody Associated Vasculitis Trial in Overland Park (STSA-1002 subcutaneous injection)

Recruiting
  • Antineutrophil Cytoplasmic Antibody Associated Vasculitis
  • STSA-1002 subcutaneous injection
  • Overland Park, Kansas
    AltaSciences Clinical Kansas, Inc
Feb 2, 2023

Non-alcoholic Steatohepatitis (NASH) Trial in Berlin (NNC0194-0499)

Not yet recruiting
  • Non-alcoholic Steatohepatitis (NASH)
  • Berlin, Germany
    Novo Nordisk Investigational Site
Feb 17, 2023

Hepatic Impairment Trial in Kistarcsa, Bratislava (Fazirsiran)

Not yet recruiting
  • Hepatic Impairment
  • Kistarcsa, Hungary
  • +1 more
May 26, 2023

Healthy Subjects Trial in SEoul (C1K, Placebo)

Recruiting
  • Healthy Subjects
  • SEoul, Korea, Republic of
    Seoul National University Clinical Trial Center
Aug 3, 2023

Achondroplasia Trial in Dallas (BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe)

Recruiting
  • Achondroplasia
  • BMN 111 administration via Injector Pen
  • BMN 111 administration via vial and syringe
  • Dallas, Texas
    Labcorp
Apr 2, 2023

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

Healthy Participants Trial in Cincinnati (Olezarsen)

Recruiting
  • Healthy Participants
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Nov 29, 2022

Progressive Multiple Sclerosis Trial in Berlin (GZ402668, Placebo, Acyclovir)

Completed
  • Progressive Multiple Sclerosis
  • Berlin, Germany
    Investigational Site Number 276001
Apr 22, 2022

Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin

Not yet recruiting
  • Type 1 Diabetes Mellitus
  • +2 more
  • Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
  • Winston-Salem, North Carolina
    WakeForest University Health Sciences
May 11, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

Healthy Trial in Ahmedabad (Enoxaparin Sodium (Venus Remedies Limited), Enoxaparin Sodium (Sanofi))

Completed
  • Healthy
  • Enoxaparin Sodium (Venus Remedies Limited)
  • Enoxaparin Sodium (Sanofi)
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Mar 2, 2022

Healthy Trial in Shenzhen (TB001, Placebo)

Recruiting
  • Healthy
  • Shenzhen, Guangdong, China
    Shenzhen Turier Biotech Co., Ltd.
Apr 4, 2022

Healthy Volunteers Trial in Madrid (PBP1502, EU-licensed Humira, US-licensed Humira)

Recruiting
  • Healthy Volunteers
  • Madrid, Spain
    Unidad de Fase I. U. Autonoma de Madrid (Clinical Trials Unit, U
Sep 26, 2022

Renal Insufficiency, Healthy Trial in Miami, Orlando, Saint Paul (LY3819469)

Not yet recruiting
  • Renal Insufficiency
  • Healthy
  • Miami, Florida
  • +3 more
Apr 24, 2023